Fact CheckerSign in

NCT05546099Active, not recruiting

Patient-driven Management of BP in CKD

Pharmacist-guided, Patient-driven Management of High Blood Pressure in CKD: A Novel Approach

Source: ClinicalTrials.gov · Last updated 23 Oct 2026

Brief summary (registry, in English)

The proposed research will evaluate if patients managing their blood pressure medications under the guidance of a clinical pharmacist works better to lower blood pressure than patients monitoring their blood pressure at home and the standard care. 60 Veterans with chronic kidney disease (CKD) will be included in the study. The study will further evaluate factors that may influence the Veteran to accept the self-management approach and what factors in the VHA healthcare system affect the implementation of the self-management approach.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
160 (actual)
First submitted
14 Sept 2022
Start date
15 Dec 2022
Primary completion date
15 Dec 2026
Lead sponsor
VA Office of Research and Development
NCT number
NCT05546099

What you commit to

  • Study type: Interventional
  • Participants enrolled: 160
  • From 15 Dec 2022 to the primary completion date, 15 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Severely uncontrolled hypertension defined as systolic blood pressure (BP)\>180
  • Patients with resistant hypertension and taking 4 blood pressure medications
  • Severe chronic kidney disease defined as estimated glomerular filtration rate \< 20 milliliters per minute /1.73 square meters
  • Severe liver disease
  • Severe congestive heart failure
  • Severe cognitive decline due to dementia

Other

  • Orthostatic hypotension defined as reduced systolic blood pressure by 20 millimeters of mercury or diastolic blood pressure by 10 millimeters of mercury after 3 minutes of standing
  • Life expectancy \<1 year
  • Pregnant, breastfeeding, or unwilling to use adequate birth control

Who the study is looking for

  • Chronic kidney disease stage 3 or 4 (estimated glomerular filtration rate: 15-59 milliliters per minute /1.73 square meters) or
  • Stage 2 chronic kidney disease (estimated GFR 60-89 milliliters per minute/1.73 square meters) with urinary albumin/creatinine ratio (ACR 300 milligrams per gram if no diabetes mellitus and 30 milligrams per gram if with diabetes mellitus), and
  • Uncontrolled hypertension defined as the avg of 2 readings \> 140 systolic

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Iowa City VA Health Care System, Iowa City, IA
Coordinator of this site? Confirm its status
Iowa CityUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.